Patterns of antihypertensive prescribing, discontinuation and switching among a Hong Kong Chinese population from over one million prescriptions

Journal of Human Hypertension

Volumn 22, Issue 10, 2008, Pages 714-716

  Wong, M C S ^a   Jiang, J Y ^a   Lam, A T ^b   Fung, H ^b   Griffiths, S ^a   Mercer, S W ^a,c  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; THIAZIDE DIURETIC AGENT;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHINESE; CONTROLLED STUDY; DRUG CHOICE; DRUG SUBSTITUTION; DRUG UTILIZATION; DRUG WITHDRAWAL; ELECTRONIC MEDICAL RECORD; ETHNIC DIFFERENCE; FEMALE; HEALTH INSURANCE; HONG KONG; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PRESCRIPTION; PRIMARY HEALTH CARE; PUBLIC HEALTH; SEX DIFFERENCE; TREND STUDY;

ANTIHYPERTENSIVE AGENTS; HONG KONG; HUMANS; HYPERTENSION; PHYSICIAN'S PRACTICE PATTERNS;

EID: 52749095140     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2008.83     Document Type: Article

References (12)

1. SHEP Cooperative Research Group. Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. JAMA 1991; 265: 3255-3264.
2. Wong MCS, Jiang Y, Tang JL, Lam A, Fung H, Mercer SW. Health services research in the public healthcare system in Hong Kong: An analysis of over 1 million antihypertensive prescriptions between 2004-2007 as an example of the potential and pitfalls of using routinely collected electronic patient data. BMC Health Ser Res 2008; 8: 138.
3. Population by-census, 2006. Hong Kong Special Administrative Region, China. Available at: http://www.bycensus2006.gov.hk/data/data2/ index.htm. Accessed 11, November, 2007.
4. Yuen YH, Chang S, Chong CK, Lee SC, Critchley JA, Chan JC. Drug utilization in a hospital general medical outpatient clinic with particular reference to antihypertensive and antidiabetic drugs. J Clin Pharm Ther 1998; 23(4): 287-294.
5. Cheung BM, Wong YL, Lau CP. Queen Mary Utilization of Antihypertensive Drugs Study: Use of antihypertensive drug classes in the hypertension clinic 1996-2004. Br J Clin Pharmacol 2005; 60(1): 90-97.
6. Ma J, Lee K-V, Stafford RS. Changes in antihypertensive prescribing during US outpatient visits for uncomplicated hypertension between 1993 and 2004. Hypertension 2006; 48: 846-852.
7. Walley T, Duggan AK, Haycox AR, Niziol CJ. Treatment for newly diagnosed hypertension: Patterns of prescribing and antihypertensive effectiveness in the UK. J R Soc Med 2003; 96: 525-531.
8. Onder G, Gambassi G, Landi F, Pedone C, Cesari M, Carbonin P, et al. on behalf of Investigators of the GIFA Study (SIGG-ONLUS). Trends in antihypertensive drugs in the elderly: The decline of thiazides. J Hum Hypertens 2001; 15: 291-297.
9. Kabir Z, Feely J, Bennett K. Primary care prescribing patterns in Ireland after the publication of large hypertension trials. Br J Clin Pharmacol 2007; 64(3): 381-385.
10. Mori H, Ukai H, Yamamoto H, Saitou S, Hirao K, Yamauchi M et al. Current status of antihypertensive prescription and associated blood pressure control in Japan. Hypertens Res 2006; 29: 143-151.
11. Fretheim A, Oxman AD. International variation in prescribing antihypertensive drugs: Its extent and possible explanations. BMC Health Ser Res 2005; 5: 21.
12. National Collaborating Centre for Chronic Conditions. Hypertension: Management in Adults in Primary Care: Pharmacological Update. Royal College of Physicians: London, 2006.